POS0660 SURVIVAL AND SAFETY OF BIOLOGICAL AND TARGETED SYNTHETIC THERAPIES. 10 YEARS OF REAL-LIFE DATA. BIOABASAR 3.0 REGISTRY
A. Brigante,C. A. Isnardi,R. Quintana,G. Gomez,K. Roberts,M. Haye,A. C. Costi,N. Perez,P. Astesana, A. M. Smichowski,L. Sorrentino,J. Alcivar Navarrete, J. C. Raggio,M. Viola,V. Saurit,I. E. Petkovic, K. I. Kirmayr,E. Catay,M. E. D'Angelo,B. Pons-Estel,S. Paira,G. Bovea Castelblanco,M. E. De la Sota,M. S. Larroude,D. A. Pereira, A. B. Granel,N. Callahuara,G. Medina,C. Pisoni,A. Alvarez,L. Fernandez,M. Sacnun,S. Soares de Souza,E. Velozo,N. Aste,E. Kerzberg, M. D. L. A. Gallardo,V. Savio,J. Gamba,G. Citera,E. Soriano,G. Casado,C. Graf,G. Pons-Estel,M. Delavega ANNALS OF THE RHEUMATIC DISEASES（2022）
Key words
Biological Therapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper